<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7657A812-BA6C-4896-9696-9E3392BC4F6E"><gtr:id>7657A812-BA6C-4896-9696-9E3392BC4F6E</gtr:id><gtr:name>The Leverhulme Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6CA57AEB-A5D2-4904-AC75-1660A208E544"><gtr:id>6CA57AEB-A5D2-4904-AC75-1660A208E544</gtr:id><gtr:name>Nidderdale High School</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Physics and Astronomy</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7657A812-BA6C-4896-9696-9E3392BC4F6E"><gtr:id>7657A812-BA6C-4896-9696-9E3392BC4F6E</gtr:id><gtr:name>The Leverhulme Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6CA57AEB-A5D2-4904-AC75-1660A208E544"><gtr:id>6CA57AEB-A5D2-4904-AC75-1660A208E544</gtr:id><gtr:name>Nidderdale High School</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/56259AA0-A670-4B57-A970-CFDC3B571559"><gtr:id>56259AA0-A670-4B57-A970-CFDC3B571559</gtr:id><gtr:name>Epigem Ltd</gtr:name><gtr:address><gtr:line1>Malmo Court</gtr:line1><gtr:line2>Kirkleatham Business Park</gtr:line2><gtr:line3>Redcar</gtr:line3><gtr:line4>Cleveland</gtr:line4><gtr:postCode>TS10 5SQ</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F694D72A-210B-4BBC-90FC-8DB1EA5CDF07"><gtr:id>F694D72A-210B-4BBC-90FC-8DB1EA5CDF07</gtr:id><gtr:name>Precision Acoustics Ltd</gtr:name><gtr:address><gtr:line1>Hampton Farm Business Park</gtr:line1><gtr:line2>Higher Bockhampton</gtr:line2><gtr:line4>Dorchester</gtr:line4><gtr:line5>Dorset</gtr:line5><gtr:postCode>DT2 8QH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/35959349-7BD2-4B7E-854E-961C1FDA4091"><gtr:id>35959349-7BD2-4B7E-854E-961C1FDA4091</gtr:id><gtr:name>Weidlinger Associates Inc</gtr:name><gtr:address><gtr:line1>399 West El Camino Real, Suite 200</gtr:line1><gtr:line4>Mountain View</gtr:line4><gtr:line5>CA 94040</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C92E64AC-9FFD-4663-A51C-72D950AE2651"><gtr:id>C92E64AC-9FFD-4663-A51C-72D950AE2651</gtr:id><gtr:name>Leeds and West Riding Medical Research</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/949B9445-CBE8-4466-B666-564F50F073AB"><gtr:id>949B9445-CBE8-4466-B666-564F50F073AB</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:otherNames>Fred</gtr:otherNames><gtr:surname>Markham</gtr:surname><gtr:orcidId>0000-0002-6639-3199</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0A441683-6E2F-4373-BDA2-3D5D17F775B8"><gtr:id>0A441683-6E2F-4373-BDA2-3D5D17F775B8</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8D921659-9DC3-4543-BDFD-B87669F32F1B"><gtr:id>8D921659-9DC3-4543-BDFD-B87669F32F1B</gtr:id><gtr:firstName>J. Anthony</gtr:firstName><gtr:surname>Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A6886466-C969-43E4-8ECB-0BC1C9C09EE8"><gtr:id>A6886466-C969-43E4-8ECB-0BC1C9C09EE8</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:surname>Freear</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4D7D6523-5469-4A8F-A9CC-6D5516572902"><gtr:id>4D7D6523-5469-4A8F-A9CC-6D5516572902</gtr:id><gtr:firstName>Pamela</gtr:firstName><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/786917C9-82FE-4052-A96A-063EB2DFB57E"><gtr:id>786917C9-82FE-4052-A96A-063EB2DFB57E</gtr:id><gtr:firstName>Patricia</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Coletta</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AAC64792-EC77-4C8D-826A-516AECCE2799"><gtr:id>AAC64792-EC77-4C8D-826A-516AECCE2799</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Henderson</gtr:otherNames><gtr:surname>Thomson</gtr:surname><gtr:orcidId>0000-0001-7332-790X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/46E97B74-0CD9-4B3A-A9F9-E791019B8A58"><gtr:id>46E97B74-0CD9-4B3A-A9F9-E791019B8A58</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Bushby</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FI000623%2F1"><gtr:id>C63624D7-EC36-42BA-A700-C6233DE43938</gtr:id><gtr:title>Engineering Therapeutic Microbubbles</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/I000623/1</gtr:grantReference><gtr:abstractText>Colorectal Cancer (CRC) is the third most common cancer in the UK, with approximately 32,300 new cases diagnosed and 14,000 deaths in England and Wales each year. Occurrence of colorectal cancer is strongly related to age, with 83% of cases arising in people older than 60 years. It is anticipated that as our elderly population increases, CRC will increase in prevalence (National Institute for Clinical Excellence, www.nice.org.uk). This raises important questions relating to treatment in elderly patients balanced with quality-of-life and health economics considerations. The challenge to nanotechnology and engineering is to deliver cost-effective, less invasive treatments with fewer side-effects and potential benefits for quality of life in patients. This is particularly important in CRC at the present time as the NHS bowel-screening programme is rolled out for all individuals aged 60 to 69. This raises important issues for rapid, accurate, and acceptable, safe and cost-effective investigation and treatment of older symptomatic patients. Ultrasound has a clear and growing role in modern medicine and there is increasing demand for the introduction of ultrasound contrast agents such as microbubbles (MBs). These MBs are typically less than one hundredth of a millimetre in size, so that they can pass through the vasculature, and lead to imaging enhancements by scattering of the ultrasound signal. So-called third generation MBs will not only perform functional imaging with greatly enhanced sensitivity and specificity but will also carry therapeutic payloads for treatment or gene therapy. These will most likely be released by destroying the bubbles at the targeted site and their effect enhanced further by sonoporation (sound induced rupture of the cell walls to allow drugs in). Although the focus of our proposal is therapeutic delivery for cancer treatment, the basic technologies for MB development and ultrasound technology are equally applicable to other conditions e.g. cardiovascular and musculoskeletal disease where there is an unmet clinical need, particularly in ageing populations. As such this is a generic technology development relevant to different diseases.Our programme of research addresses several key issues central for the successful development of these 3rd Generation MBs. Firstly, we propose to develop a machine, based on microfluidics, for the creation of MBs of uniform size (necessary for human application). This instrument will also allow us to put suitable coatings on the MBs to target them specifically at cancerous cells. Secondly, we will develop novel coatings to allow control over the way bubbles respond to ultrasound signals. We will then add payloads of the required drug to be delivered onto the micro-bubble surface. At the same time we will develop novel methods of generating ultrasound signals which can be used to selectively destroy the MBs and simultaneously create holes in the cells to which the drugs should be delivered. A necessary part of such a programme of research is the full testing and evaluation of the MBs developed for targeted therapy of CRC using a combination models. Firstly, against cancer cells grown in test tubes and secondly, against mice infected with the relevant cancer. At the conclusion of our research project we will have enhanced our understanding of how MB and ultrasound technologies can be combined to yield new routes for therapeutic delivery/gene therapy. This will provide a platform to launch the next stage of research, required before such an approach could be used clinically.</gtr:abstractText><gtr:potentialImpactText>The research proposed here would have a combination of short- and long-term beneficiaries. Most directly, and immediately, affected will be those engaged in translational research, especially that involving the training of new PDRAs and PhDs, within the University of Leeds. For these it will serve to reinforce the benefits of following a multidisciplinary approach to targeting specific medical problems. This project will broaden the base of researchers engaged in therapeutic delivery through a combination of open internal meetings, such as the journal club, and a project seminar programme. Outside the University of Leeds there are other beneficiaries, both academic and industrial who will be users of the research outputs in the medium-term. For example, researchers engaged in the development of ultrasound contrast agents and also those wishing to establish new delivery modes will benefit from having an instrument for the facile and low-cost production of microbubbles (MBs) with improved control over MB size and surface coating. Access to both the microfluidic chips and microbubble instrumentation will be ensured through our commercialisation of this product. In this respect local commerce (private sector) will also be a beneficiary of this research. In the medium-term we will deliver improved understanding in the relationship between the MB coating and ultrasound (US) response and improved mechanisms for US controlled drug release, which will help a number of researchers, develop improved protocols for therapeutic delivery and/or enhance preclinical investigations. Dissemination of our research outputs will be achieved through our organisation of an annual symposium, through publication in high impact journals and via presentations at relevant international meetings. In the longer term this research will lead to new, more effective modes of therapeutic delivery thereby allowing reduced systemic exposure to potent drugs and concomitantly reduced cost and hence will therefore be of interest to big pharma and charitable organisations engaged with improving the treatment of disease. At this early stage we have made contact with a number of large charitable organisations and relevant pharmaceutical companies (from whom we have letters of support) and will keep these companies informed of our progress during the project as well as welcoming them to our annual meetings. The ultimate beneficiaries would be clinicians involved in the deliver of, and the general public as primary recipients of, the technology to be developed. These would benefit from improved efficacy of treatment with reduced side effects and overall improvement in the quality of life, and life expectancy. Finally, the reduced drug content and associated severity of side effects should lead to a reduction in the overall cost of treatment, and, thus could benefit taxpayers.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2010-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1220831</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Conducting Polymer for Cancer Therapy</gtr:description><gtr:id>0A6A1268-420E-471B-8109-37571584121C</gtr:id><gtr:outcomeId>b965c3c2b965c3d6-1</gtr:outcomeId><gtr:piContribution>in Wellcome Trust Institutional Strategic Support Fund (ISSF) Junior Investigator Development Fellowship</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Leverhulme Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Nanobombs for breast cancer diagnosis and therapy</gtr:description><gtr:id>94E6B600-CF3E-4DD6-8B16-A31EDAB84AD6</gtr:id><gtr:outcomeId>b96442c2b96442e0-1</gtr:outcomeId><gtr:piContribution>Early Career Fellowship from The Leverhulme Trust, reference ECF-2013-247. 36 months.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nidderdale High School</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Laboratory Visit - Nidderdale High School</gtr:description><gtr:id>530EA20D-F1D2-4B2E-A779-631092D69EB3</gtr:id><gtr:outcomeId>b9d5ee4ab9d5ee5e-1</gtr:outcomeId><gtr:piContribution>October 2012

Widening participation and research engagment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Li Ka Shing Institute of Health Sciences at the Chinese University of Hong Kong</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5BCF25F6-604E-4C28-B7FF-E92AC53A24BB</gtr:id><gtr:impact>Steering Committee Member, 2007-2010 .</gtr:impact><gtr:outcomeId>r-9706524358.7889942b8af640</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Charles Rodolphe Brupbacher Stifung</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0D0A481E-C765-4A0A-9762-D3607DB915A3</gtr:id><gtr:impact>Zurich, Scientific Advisory board to the Foundation member, 2012 to present .</gtr:impact><gtr:outcomeId>r-2860741580.70678042b8ae6a0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Snap, Crackle &amp; Pop - an update on contrast microbubble research in Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C841D002-DAFC-430D-A567-A1275AE36C69</gtr:id><gtr:impact>MNP Seminar, University of Leeds.



Dr Carmel Moran, Reader in Medical Physics, University of Edinburgh.</gtr:impact><gtr:outcomeId>r-8014510281.3975060bc635d8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Department of Health, Senior Responsible Owner and Board Chairman</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>63432161-F3B3-4868-B3FC-BA40A192BB26</gtr:id><gtr:impact>NIHR/NHS Connecting for Health, Research Capability Programme, 2007-2012 .</gtr:impact><gtr:outcomeId>r-552158644.93712652b8aebc8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imaging the tumour microenvironment with contrast enhanced high frequency ultrasound</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2E1E90FA-A61E-4218-B2F2-6699D5C1FF12</gtr:id><gtr:impact>Sheffield, Cancer Research Centre 2013

Invited presentation.</gtr:impact><gtr:outcomeId>r-3651628646.67515130ca50d3a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Oncology Forum</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EB3CD62C-9D8F-43D7-90FE-D48060D031D2</gtr:id><gtr:impact>Invited member - 2012 to present .</gtr:impact><gtr:outcomeId>r-6815056956.2009132b8b0996</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Agency for Research on Cancer (IARC/WHO)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AC16D4B6-64E2-4BAC-A5F5-57C64E39F98C</gtr:id><gtr:impact>UK-nominated Fellowships Committee Member - 2012 to present .</gtr:impact><gtr:outcomeId>r-2440763453.43213842b8af258</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBSRC: The Genome Analysis Centre</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A79C1E60-C621-4103-A696-825E435EA04F</gtr:id><gtr:impact>Institute Board Chairman, 2010 - 2012 .</gtr:impact><gtr:outcomeId>r-1905467558.56412222b8ae2a4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Network for Cancer Treatment and Research</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3021E2BB-8661-4234-BFCC-6A675F078EE2</gtr:id><gtr:impact>INCTR/WHO, building capacity for cancer control in developing countries



Governing Council Member , 2011 to present .</gtr:impact><gtr:outcomeId>r-1405762882.3497922b8af366</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The use of light, sound and microbubbles for molecular imaging and therapy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>058463B7-AEC7-400F-9E43-79A73011CDE0</gtr:id><gtr:impact>Invited talk at the Institute of Cancer Research.

Invited talk in London</gtr:impact><gtr:outcomeId>r-1374959825.88730740bc63948</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Department of Health</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6D85E73A-4AC6-41C1-B1F7-62BC4462CCA0</gtr:id><gtr:impact>NIHR/MHRA, Chairman, Clinical Practice Research Datalink, Expert Advisory group, 2012 to present .</gtr:impact><gtr:outcomeId>r-7204884772.3797752b8ae8ee</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR Clinical Research Facilities for Experimental Medicine</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D0EC28D9-AFB9-48DA-94BC-6AA223F59F29</gtr:id><gtr:impact>Funding panel - Chairman 2011 to present .</gtr:impact><gtr:outcomeId>r-9339472455.2887232b8afb72</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR Research Capability Programme</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8A6C9BFC-CE5A-487E-934C-1A7AD7E398BD</gtr:id><gtr:impact>Senior Responsible Owner .</gtr:impact><gtr:outcomeId>r-9326079077.3910272b8afcb2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Singapore National Medical Research Council</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5CE5CE34-0407-407A-A210-57876EEFF806</gtr:id><gtr:impact>Translational and Clinical research flagship programme review panel member 

2012 to present .</gtr:impact><gtr:outcomeId>r-4366637071.9360532b8b05ae</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Deutsche Krebshilfe Programme for the development of interdisciplinary Oncology Centres of excellence in Germany</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>93129D39-D269-4D11-8F2F-ECF7B17F9F8B</gtr:id><gtr:impact>Clinical Advisory Board Member

2008 to present .</gtr:impact><gtr:outcomeId>r-1146139214.88275672b8aed12</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Optimisation of microbubble and ultrasound technologies for the diagnostic and therapy of colorectal cancer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D7440CE5-6AF2-48FB-B4C8-05F12376DC61</gtr:id><gtr:impact>Talk at IMSAT.

Invited talk In Dundee</gtr:impact><gtr:outcomeId>r-7716047724.4444640bc62f84</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Counter flow microbubble channelling using acoustic radiation force funnel</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5A60BADE-E930-45D4-A1B5-F6911D148FE4</gtr:id><gtr:impact>Leeds Oncological Engineering Conference, University of Leeds 2011



Prize winning poster.</gtr:impact><gtr:outcomeId>r-4115902766.6932930bc62c14</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Matrix metalloproteinase-9, Neutrophil Gelatinase-Associated Lipocalin and tumour endothelial markers in Perihilar Cholangiocarcinoma: Developing biomarkers for targeted therapies</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>65679D4D-4EC1-454C-AAB4-7D82A02CA1DC</gtr:id><gtr:impact>Association of Surgeons of Great Britain and Ireland (ASGBI) International Surgical Congress, Glasgow May 2013

Invited presentation.</gtr:impact><gtr:outcomeId>r-7235643106.7321840cb5a5be</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview - Women's Day</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B87E67A6-69D3-472A-A80F-C97C6916149B</gtr:id><gtr:impact>Radio interview on BBC 106.6 fm for as part of 'women's day' that featured women from a variety of professions talking about their work 



Bradford Community Broadcasting, Bradford, UK.</gtr:impact><gtr:outcomeId>r-2003870114.6877090ca61838</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford University Vaccines Oversight Committee Chairman</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3516F2C3-3B37-470C-A40B-A4E5759D0B50</gtr:id><gtr:impact>2012 to present .</gtr:impact><gtr:outcomeId>r-9572338908.512462b8b01d0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Arthritis Research UK</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>685266D3-655F-454A-9294-9F34E9CA631E</gtr:id><gtr:impact>Chairman Scientific Strategy Committee and Trustee

2009 to present .</gtr:impact><gtr:outcomeId>r-6603969770.11484052b8ae0d8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centre for Drug Safety Science</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD824971-3454-46D7-BA8E-7C454F127033</gtr:id><gtr:impact>University of Liverpool

Scientific Advisory Board member - 2009 to present .</gtr:impact><gtr:outcomeId>r-4315333454.2320422b8af78a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tumour Vascular profiling with contrast enhanced high frequency ultrasound (Dublin 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E71EF6C0-36C0-466F-8B1E-ECFCA9630655</gtr:id><gtr:impact>Invited Presentation

March 2013, Dublin, Royal College of Surgeons.</gtr:impact><gtr:outcomeId>r-861637909.7678120ca51140</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OSCHR/NOCRI Therapeutic Capability Clusters Delivery and Oversight Group member</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CF5C36F0-C14B-4A53-A934-E0B27B3E9ECE</gtr:id><gtr:impact>2009-2012 .</gtr:impact><gtr:outcomeId>r-5081654717.2904532b8b0086</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Leeds microbubble symposium: fabrication, characterisation and translational applications (Leeds 2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>037A0349-AF6D-4E03-96F4-39C5175F730E</gtr:id><gtr:impact>'High on-chip production rates and mechanical characterisation of therapeutic microbubbles for targeted drug delivery' - oral presentation.</gtr:impact><gtr:outcomeId>r-6457727892.7506210bfa4832</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab Visit - Sounding out Bubbles</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>927A43C6-9C13-4E57-ABE9-D836AB8D5F56</gtr:id><gtr:impact>A novel approach to treating cancer

Lab visit and presentation

Myeloma Support group, October 2012.</gtr:impact><gtr:outcomeId>r-6852541181.1215260bfb1582</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Berlin Institue of Health</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F98CF4E6-5B17-4A6B-BA9E-E11CB02322B0</gtr:id><gtr:impact>German Federal Ministry of Education and Research (BMBF), Scientific Review Panel Member - 2013 ro present .</gtr:impact><gtr:outcomeId>r-9715428789.812542b8ae588</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Daniel Turnberg Trust Panel Member</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EDA57D08-B2D3-4CCD-AAEB-34C385430C5A</gtr:id><gtr:impact>Academy of Medical Sciences

2008 to present .</gtr:impact><gtr:outcomeId>r-5157421841.4327342b8ae7ea</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>German Consortium for Translational Cancer Research of the Federal Ministry of Education and Research (DKTK)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ED6F3D0D-6E5A-436B-B590-CBA734EE53D8</gtr:id><gtr:impact>Review panel chairman - 2010 to present

Scientific Advisory Board member - 2013 to present .</gtr:impact><gtr:outcomeId>r-4074220446.9388542b8aee2a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Senior Medical Advisor</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9D7C37D-65B2-401B-A6B4-02C9DCD5A0F2</gtr:id><gtr:impact>Cancer Research UK

2007 to present .</gtr:impact><gtr:outcomeId>r-2616730698.02739762b8b04aa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Cancer Intelligence Network</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B002659B-6768-4923-9278-719AC3D62449</gtr:id><gtr:impact>Steering Group Chairman

2006 to present .</gtr:impact><gtr:outcomeId>r-2457094502.129682b8af8a2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR Senior Investigtors Appointment Panel</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6F59C114-3535-43C9-BEC9-6FDD6F565E17</gtr:id><gtr:impact>2007 to 2010 - Member

2011 to 2014 - Chairman .</gtr:impact><gtr:outcomeId>r-8611978328.4254172b8afdc0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Probing the effect of Poly(ethylene glycol) on the mechanical behaviour of Streptavidin and quantum dot coated microbubbles</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>88F81EF1-59F3-478F-98C7-12F65A825B18</gtr:id><gtr:impact>UK Scanning probe microscope conference (Edinburgh, UK, 2011).</gtr:impact><gtr:outcomeId>r-6232530629.4788890bc6329a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sir Jules Thorn Medical Research Trust International Autozygosity Mapping Resource</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F0AC7E0D-01D2-4DF1-813B-D988D066537E</gtr:id><gtr:impact>Steering Group Chairman, 2009 to present .</gtr:impact><gtr:outcomeId>r-3982993572.93452452b8b086a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tumour vascular profiling with contrast enhanced high frequency ultrasound (London 2011)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4911B04D-BE9B-4734-99DD-BAFF108CFA25</gtr:id><gtr:impact>British medical ultrasound pre-clinical imaging workshop, 2011 London

Invited presentation.</gtr:impact><gtr:outcomeId>r-31463792.576886520bc63fb0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nanomechanical properties of therapeutic microbubbles</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>463A5948-0CA5-4D00-A670-41FDB9359336</gtr:id><gtr:impact>Oral session

UK scanning probe microscope conference.</gtr:impact><gtr:outcomeId>r-363304708.49136330ca50e66</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The use of optically activated nanoparticles under tension to enhance photoacoustic imaging and high intensity focused ultrasound exposures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1563BDAB-B946-4302-80C2-8DB9BB80CA27</gtr:id><gtr:impact>Invited talk at IMSAT.

Invited talk in Dundee</gtr:impact><gtr:outcomeId>r-2831268592.58047150bc63c72</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>German Helmholtz Association (DKFZ, MDC, HZDR)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>488307DF-D26A-42E6-90CC-93DD2D786ACD</gtr:id><gtr:impact>Cancer Research Programme, Internation Review Panel member

2013 to present .</gtr:impact><gtr:outcomeId>r-6932684897.3824512b8af104</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Academy of Medical Sciences</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1AFC10AF-E63A-40EA-880E-ADBF0C39D1B8</gtr:id><gtr:impact>Clinical Academic Careers Committee Member

2008-2011 .</gtr:impact><gtr:outcomeId>r-3704793866.4488442b8adf98</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>689430</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Microbubbles for hydrophobic drug delivery and enhanced diagnostics; towards personalised healthcare for the treatment of colorectal cancer</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>32C76848-6FB9-4B4F-95A3-C43F4F53B1AA</gtr:id><gtr:outcomeId>5ed809b65ed809ca</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Microfluidics aspect is being commercialised to set-up a spinout for the production of instruments for microbubble and droplet formation. We are currently in discussion with the Medicines Discovery catapult on how to move the commercialisation forward. As part of this we are attending the North of England accelerator boot camp event to aid commercialisation. Within Leeds we have refined and defended key patents held around the Horizon instrument.

research has led to follow-on funding for the treatment of cancer and has widened the number of researchers in the field. 

The research symposia associated with this grant led to the world leaders from USA and Holland, Japan, Spain, France and Germany to come to Leeds. A number of companies attending this meeting have made sales through associated meeting.

New clinical ultrasound /microbubble areas emerging</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>DA707DD5-94E5-412C-AC65-B5D50033D0C8</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>545fe8a16c8405.18107267</gtr:outcomeId><gtr:sector>Education,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>UK Patent number: 1222882.1, 2012 publication number WO2014096789 A2 application number PCT/GB2013/053289 filed</gtr:description><gtr:grantRef>EP/I000623/1</gtr:grantRef><gtr:id>22F71872-52BE-4FC0-ADA6-2789B5A181B2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>r-5081881531.590486ff49df34</gtr:outcomeId><gtr:patentId>WO2014096789 A2</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Ultrasound Generation (Patent)</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The patent is on the generation of microbubbles using a microfluidic device that features a 3D expanding geometry. The patent also covers the one-step microfluidic approach for functionalising the surface of the microbubbles WO/2013/001309 3/1/2013 International application number: PCT/GB2012/051524 International filing dat: 29 JUne 2012</gtr:description><gtr:grantRef>EP/I000623/1</gtr:grantRef><gtr:id>690DDE5C-4A6D-4022-BBE1-586C12DE951C</gtr:id><gtr:impact>Discovery of ability to create nano bubbles - in novel way.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>r-3285109040.5928984ff49e254</gtr:outcomeId><gtr:patentId>WO2013001309</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Bubble Generation (Patent)</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>The Key Scientific Outcomes are; i) Development of a new mF 'spray-regime' capable of producing MBs of clinically relevant sizes and concentration (GB1111082.2).1 ii) Demonstration of methods for the on-chip manipulation of MBs using electric fields (GB1111081.4). iii) Production of three prototype instruments with excellent reproducibility across multiple users / locations capable of producing monodisperse MBs.1 iv) Demonstration of the addition of therapeutic payloads, Irinotecan, Doxorubicin, as well as fluorophores (Luciferin, Qdots and dyes) in the form of antibody labelled pegylated-liposomes. v) Improved in vivo MB lifetimes, over commercially available imaging-MBs. vi) The first determination of the mechanical properties of lipid-shelled bubbles at clinically relevant temperatures using AFM.2 vii) The programming of arbitrary ultrasonic sequences onto a medical phased array transducer3,4 (GB1222882.1) using the University of Leeds (UoL) built Ultrasound Array Research Platform (UARP). viii) Development of the acoustic trap for increasing local MB concentration (GB1205158.7)5, ix) Development of a sonoporation test-bed, where the efficacy of acoustic pulse regimes were explored for CRC cell lines and tumours in nude mice.6 x) Demonstration that mF MBs are stable and non-toxic, can be targeted, and bind to endothelial cells6 and tumour cells6 under flow conditions in vitro and in vivo. xi) Improved uptake in human CRC xenografts of luciferin as a model drug when targeted to tumour vasculature via anti-VEGFR2 antibody. xii) Improved in vitro uptake of a model drug using MBs combined with CHIRP sequences.7 xiii) Demonstration that high-frequency US can be used to simultaneously image tumour growth/development and provide quantitative perfusion data in vivo in mouse models of CRC, xiv) Demonstration that high frequency ultrasound can be used to image and measure colon wall thickness in vivo over time8 and image adenomas in the mouse colon9. This extends the range of mouse models suitable for translational studies of targeted, US triggered therapeutic MBs.</gtr:description><gtr:exploitationPathways>As part of this project we are developing a platform for preclinical, in vitro and in vivo investigations, of sono-enhanced drug delivery. We expect this to be of use to a wide range of SME and larger pharmaceutical companies.



In the longer term we expect therapeutic delivery to be taken into the the clinic providing a more efficient route for therapeutic delivery with improved patient outcome and reduced side effects. Outside the University of Leeds there are other beneficiaries, both academic and industrial who will be &amp;quot;users&amp;quot; of the research outputs in the medium-term. For example, Epigem Ltd, a long-standing partner in our research, will exploit the commercial development of the instrumentation to provide microfluidic system for sale to researchers and companies engaged in CEUS imaging and therapeutic delivery. The research undertaken in this project has led to the development of a new instrument the &amp;quot;Horizon&amp;quot; a microfluidics based microbubble instrument developed (http://epigem.co.uk/latest-news/epigem-and-university-of-leeds-unveil-first-microbubble-instrument-the-horizon) for the on demand production of targeted micro bubbles. Researchers engaged in targeted imaging and therapeutic delivery will now have access to simple low cost routes for on demand production of monodisperse and spray regime produced MBs. Importantly they will be able to specify in vivo lifetimes and microbubble rigidity (US response). This will allow optimisation of targeting and delivery regimens. Access to the microfluidic chips developed will be ensured through our continued links with Epigem. University of Leeds and Epigem are commercialising this instrument.





In the longer term this research will lead to new, more effective modes of therapeutic delivery thereby allowing reduced systemic exposure to potent drugs and concomitantly reduced cost and hence will therefore be of interest to big pharma and charitable organisations engaged with improving the treatment of disease. At this early stage we have maintained our contact with a number of large charitable organisations and relevant pharmaceutical companies (from whom we have letters of support) and will keep these companies informed of our progress during the project as well as welcoming them to our annual meetings.</gtr:exploitationPathways><gtr:id>E291A7A0-FE42-410A-8E57-A595866E0865</gtr:id><gtr:outcomeId>r-6464229083.121036776f0a56</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors><gtr:url>http://microbubbles.leeds.ac.uk/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International Agency for Research on Cancer (World Health Organisation)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EE1B5834-D84F-4479-99A8-B4366E0B87C4</gtr:id><gtr:impact>UK - nominated Scientific Advisory board member

2008-2012 .</gtr:impact><gtr:outcomeId>r-3786279329.831041d23e1242</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CFE9261D-C168-4933-A75F-ECA5E8C2CB56</gtr:id><gtr:title>Acousto-microfluidics: Transporting microbubble and microparticle arrays in acoustic traps using surface acoustic waves</gtr:title><gtr:parentPublicationTitle>Journal of Applied Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ebb15db2b2961807d405b9dcfe5d67b"><gtr:id>6ebb15db2b2961807d405b9dcfe5d67b</gtr:id><gtr:otherNames>O'Rorke R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53d038038432df61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BF491DC-0290-410D-B1D5-A52A9AD2C03D</gtr:id><gtr:title>Pre-clinical evaluation of VEGFR2 as an imaging biomarker and targeting molecule for therapeutic delivery using contrast-enhanced high-frequency ultrasound (2012)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da686138b4c6e2e77f258dbcd9f92457"><gtr:id>da686138b4c6e2e77f258dbcd9f92457</gtr:id><gtr:otherNames>N Ingram (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_235634793413f16bc6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5923B10B-1F51-4998-AAA0-B1EBE3794086</gtr:id><gtr:title>Diagnostic ultrasound tooth imaging using fractional Fourier transform.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on ultrasonics, ferroelectrics, and frequency control</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07f2c74a79864e3e5a04a3ac554426c"><gtr:id>b07f2c74a79864e3e5a04a3ac554426c</gtr:id><gtr:otherNames>Harput S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3010</gtr:issn><gtr:outcomeId>doi_53d05f05fcbbf8f2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D3C13F7-D944-4BA8-B9A2-9AF132F9D05A</gtr:id><gtr:title>DominantMapper: rule-based analysis of SNP data for rapid mapping of dominant diseases in related nuclear families.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e71ddee9bc0132d43e4bad9b9eb4987"><gtr:id>1e71ddee9bc0132d43e4bad9b9eb4987</gtr:id><gtr:otherNames>Carr IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>doi_53cfc5fc53d2f241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDDD468B-69E3-437D-B38C-AF16EB899D04</gtr:id><gtr:title>Pre-distorted amplitude modulated (PDAM) chirps for transducer compensation in second and sub-harmonic imaging</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14862731c4423a06fdc5f781118dc06e"><gtr:id>14862731c4423a06fdc5f781118dc06e</gtr:id><gtr:otherNames>S Freear (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_70820747861404a89e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C09AAA1-42AE-4AF3-8A6A-2D8845856164</gtr:id><gtr:title>Acoustic microbubble trapping in blood mimicking fluid</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57efcb82588fa1ebd42ca486ed4007d1"><gtr:id>57efcb82588fa1ebd42ca486ed4007d1</gtr:id><gtr:otherNames>Nie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a5f47cbe7c821.68482577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>195B6F5B-5ED0-4693-AA98-D645F58C53F3</gtr:id><gtr:title>The design of a high speed receiver system for ultrasound array research platform (UARP)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14862731c4423a06fdc5f781118dc06e"><gtr:id>14862731c4423a06fdc5f781118dc06e</gtr:id><gtr:otherNames>S Freear (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_59008270191404a948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1D6FFD0-80EA-49D4-91A4-EF2523B9314E</gtr:id><gtr:title>Self-assembly of actin scaffolds on lipid microbubbles.</gtr:title><gtr:parentPublicationTitle>Soft matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b19a2bfc0ee277b09c1c580eb06fe73"><gtr:id>2b19a2bfc0ee277b09c1c580eb06fe73</gtr:id><gtr:otherNames>Heath GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-683X</gtr:issn><gtr:outcomeId>5453961588afc3.76949137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D002A36A-4328-421D-8701-5F5ED9A2A037</gtr:id><gtr:title>Bursting bubbles with sound helps treatments hit the spot (Magazine Article)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11d9ec06a3ed3bd1c7f516a675357104"><gtr:id>11d9ec06a3ed3bd1c7f516a675357104</gtr:id><gtr:otherNames>Stephen Evans (Interviewee)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>r_4521631753caca4542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>946FD1E5-2A22-4442-9731-E629E492F5BB</gtr:id><gtr:title>Quantitation of MRI sensitivity to quasi-monodisperse microbubble contrast agents for spatially resolved manometry.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7826a3806f2814722b0b971ac8b5237b"><gtr:id>7826a3806f2814722b0b971ac8b5237b</gtr:id><gtr:otherNames>Bencsik M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5453982d267c26.49956178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>312E6686-EB67-4C6E-9C9A-544AB4D9ABF1</gtr:id><gtr:title>Experimental investigation of chirp coded excitation in ultrasound superharmonic imaging</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05bd3f2dde73b2c9c539a04beacd7656"><gtr:id>05bd3f2dde73b2c9c539a04beacd7656</gtr:id><gtr:otherNames>Arif M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:isbn>978-1-4577-0382-9</gtr:isbn><gtr:outcomeId>doi_53d06006048f0cbc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>800BE666-220F-4ECB-BBF9-81875A3CA6E3</gtr:id><gtr:title>Characterisation of Liposome-Loaded Microbubble Populations for Subharmonic Imaging.</gtr:title><gtr:parentPublicationTitle>Ultrasound in medicine &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd53563d2387a44aa201de698d88ac6e"><gtr:id>bd53563d2387a44aa201de698d88ac6e</gtr:id><gtr:otherNames>McLaughlan JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0301-5629</gtr:issn><gtr:outcomeId>585d6fca6f4417.68002347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD2F3E3F-703B-49CC-81D2-CDE32DFC4776</gtr:id><gtr:title>Mutation detection by clonal sequencing of PCR amplicons and grouped read typing is applicable to clinical diagnostics.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9930ecf6e7dbe5cc16d835b33a924435"><gtr:id>9930ecf6e7dbe5cc16d835b33a924435</gtr:id><gtr:otherNames>Chambers PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>doi_53cfc5fc53ecc4b6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A04DEF8F-01DB-4BED-907A-35EC48767ACA</gtr:id><gtr:title>Illuminator, a desktop program for mutation detection using short-read clonal sequencing.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e71ddee9bc0132d43e4bad9b9eb4987"><gtr:id>1e71ddee9bc0132d43e4bad9b9eb4987</gtr:id><gtr:otherNames>Carr IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>doi_53d00f00f7a11c35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC50E095-150C-4974-8597-194E639CD4F3</gtr:id><gtr:title>Research spotlight: microbubbles for therapeutic delivery.</gtr:title><gtr:parentPublicationTitle>Therapeutic delivery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cfbda786ba46ab2d9fb1bb37c26f09c"><gtr:id>1cfbda786ba46ab2d9fb1bb37c26f09c</gtr:id><gtr:otherNames>Peyman SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-5990</gtr:issn><gtr:outcomeId>doi_53d0890894180a92</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1B11523-D32D-42CF-B630-9CA7ACA75322</gtr:id><gtr:title>GeneScreen: a program for high-throughput mutation detection in DNA sequence electropherograms.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e71ddee9bc0132d43e4bad9b9eb4987"><gtr:id>1e71ddee9bc0132d43e4bad9b9eb4987</gtr:id><gtr:otherNames>Carr IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>doi_53d071071ceb0abd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E04C3631-5256-4BF9-92D5-688DC708D6FA</gtr:id><gtr:title>Transducer Excitation with switched-mode encoded signals for harmonic and amplitude control verified using the leach model</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14862731c4423a06fdc5f781118dc06e"><gtr:id>14862731c4423a06fdc5f781118dc06e</gtr:id><gtr:otherNames>S Freear (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_82579113871404aa74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CD5B76C-0E0D-4BB3-94DD-2129C75B2510</gtr:id><gtr:title>Developing and investigating therapeutic microbubbles - poster session</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e75c5a3edd2d6d9f2aca69670e4d6d4"><gtr:id>1e75c5a3edd2d6d9f2aca69670e4d6d4</gtr:id><gtr:otherNames>Radwa Abou-Saleh (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_247078965414031484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92BFD7AB-A694-49D8-BE09-F4AC2ADEC359</gtr:id><gtr:title>Rapid Visualisation of Microarray Copy Number Data for the Detection of Structural Variations Linked to a Disease Phenotype</gtr:title><gtr:parentPublicationTitle>Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a539e1f42b2684cd60a2a61eaf09d5e"><gtr:id>9a539e1f42b2684cd60a2a61eaf09d5e</gtr:id><gtr:otherNames>Ian M. Carr (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1988-01-01</gtr:date><gtr:outcomeId>m_40299622391384d8b2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DB59D51-FD77-4368-BEB4-D27C7D77504D</gtr:id><gtr:title>Microfluidic 3D expansion for improved microbubble production?</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfbcd528ae7fdb69f1824d5428cb0711"><gtr:id>dfbcd528ae7fdb69f1824d5428cb0711</gtr:id><gtr:otherNames>Sally Peyman (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>m_5272099659140600cc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96BE60E3-6A6F-4311-BC6A-FCD9EC56595D</gtr:id><gtr:title>Simple and efficient identification of rare recessive pathologically important sequence variants from next generation exome sequence data.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e71ddee9bc0132d43e4bad9b9eb4987"><gtr:id>1e71ddee9bc0132d43e4bad9b9eb4987</gtr:id><gtr:otherNames>Carr IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>doi_53cfc5fc5408a231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>231E5EA7-351A-405B-8177-93BC0D11D91C</gtr:id><gtr:title>Actin assembly at model-supported lipid bilayers.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b19a2bfc0ee277b09c1c580eb06fe73"><gtr:id>2b19a2bfc0ee277b09c1c580eb06fe73</gtr:id><gtr:otherNames>Heath GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>5453955bec2694.82718093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FDB6B7F-227A-4F3E-BB1C-4FC6FB2B79F8</gtr:id><gtr:title>Microfluidic production and nanomechanics of therapeutic microbubbles for targeted drug delivery - poster session</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e75c5a3edd2d6d9f2aca69670e4d6d4"><gtr:id>1e75c5a3edd2d6d9f2aca69670e4d6d4</gtr:id><gtr:otherNames>Radwa Abou-Saleh (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>m_3297338373140313e4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FCCA930-8F50-46D4-B17E-049275E8CF5B</gtr:id><gtr:title>Engineering Gold Nanotubes with Controlled Length and Near-Infrared Absorption for Theranostic Applications</gtr:title><gtr:parentPublicationTitle>Advanced Functional Materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c887b0aba6923361b29c1baaeccce85"><gtr:id>0c887b0aba6923361b29c1baaeccce85</gtr:id><gtr:otherNames>Ye S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cb75dcd83a81.19773196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D5A8B17-929B-4B4E-B535-4119EE173D7D</gtr:id><gtr:title>?Complex microbubble architectures as a new route for cancer imaging and theranostics'</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfbcd528ae7fdb69f1824d5428cb0711"><gtr:id>dfbcd528ae7fdb69f1824d5428cb0711</gtr:id><gtr:otherNames>Sally Peyman (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>m_98951018471405fffa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC3C635A-75C3-4214-AB32-A3CCDB918EC5</gtr:id><gtr:title>Expanding 3D geometry for enhanced on-chip microbubble production and single step formation of liposome modified microbubbles.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cfbda786ba46ab2d9fb1bb37c26f09c"><gtr:id>1cfbda786ba46ab2d9fb1bb37c26f09c</gtr:id><gtr:otherNames>Peyman SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn><gtr:outcomeId>doi_53d02f02faf1fd5d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73B4FE65-F8F8-499C-AD1F-7B65AAA1EEFB</gtr:id><gtr:title>A composite statistical model for ultrasound applications</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b85a0f387e5ab67cc9038114ca25fe3e"><gtr:id>b85a0f387e5ab67cc9038114ca25fe3e</gtr:id><gtr:otherNames>S Harput (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>m_35972683481404dac6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>302E146A-1310-43E3-80E6-FA09DE99422D</gtr:id><gtr:title>Harmonic cancellation in switched mode Linear Frequency Modulated (LFM) excitation of ultrasound arrays</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60a6ebe4d2bdc1b7e587a1dc3b89f7a2"><gtr:id>60a6ebe4d2bdc1b7e587a1dc3b89f7a2</gtr:id><gtr:otherNames>Cowell D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-1-4577-1253-1</gtr:isbn><gtr:outcomeId>doi_53d06006050785cd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48F02970-464A-456D-8FAA-DD9C3A62EB54</gtr:id><gtr:title>Cd-Free Quantum dots (poster)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b32e3a6a2885d3a28ac1e47344d5ba6"><gtr:id>6b32e3a6a2885d3a28ac1e47344d5ba6</gtr:id><gtr:otherNames>Kevin Critchley (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>m_347390299413ec6de2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5E2F93F-C311-45AF-B4E2-BD49610BFB13</gtr:id><gtr:title>High frequency subharmonic imaging of liposome-loaded microbubbles</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f32227cde6af904a05699d5cb06a5a"><gtr:id>c4f32227cde6af904a05699d5cb06a5a</gtr:id><gtr:otherNames>J McLaughlan (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_594072419213e41584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA57D321-351E-4D54-A073-54742EC12570</gtr:id><gtr:title>MethylViewer: computational analysis and editing for bisulfite sequencing and methyltransferase accessibility protocol for individual templates (MAPit) projects.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59c19562ad34b6db412d14a2f86612c"><gtr:id>a59c19562ad34b6db412d14a2f86612c</gtr:id><gtr:otherNames>Pardo CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_5435b385b38c083e1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B28B1047-7377-4375-8F6A-CF2EC0265460</gtr:id><gtr:title>Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+ mice.</gtr:title><gtr:parentPublicationTitle>International journal of oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9c7e985a4638fe1b6e5d88ae013ed20"><gtr:id>d9c7e985a4638fe1b6e5d88ae013ed20</gtr:id><gtr:otherNames>Marsh L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1019-6439</gtr:issn><gtr:outcomeId>doi_53d088088639d9c4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BC725D5-0A5D-4FBC-AFA2-BD2AF9607A6C</gtr:id><gtr:title>Randomized excitation: A novel ultrasound array excitation scheme</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25eb5f34a2853b6f2613a00b46cc2d00"><gtr:id>25eb5f34a2853b6f2613a00b46cc2d00</gtr:id><gtr:otherNames>Olagunju O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4673-4561-3</gtr:isbn><gtr:outcomeId>doi_53d060060561840e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D36FF77-87F4-49CB-8744-C6F6E02EF72E</gtr:id><gtr:title>Experimental investigation of the subharmonic emission from microbubbles using linear and nonlinear frequency modulated signals</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07f2c74a79864e3e5a04a3ac554426c"><gtr:id>b07f2c74a79864e3e5a04a3ac554426c</gtr:id><gtr:otherNames>Harput S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:isbn>978-1-4577-0382-9</gtr:isbn><gtr:outcomeId>doi_53d0600604d6e9ea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B84C92AE-0A87-4642-8E66-D382F416D09A</gtr:id><gtr:title>Generation of Ultrasound Pulses in Water Using Granular Chains with a Finite Matching Layer</gtr:title><gtr:parentPublicationTitle>Physical Review Applied</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07f2c74a79864e3e5a04a3ac554426c"><gtr:id>b07f2c74a79864e3e5a04a3ac554426c</gtr:id><gtr:otherNames>Harput S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a5f47ea3e5165.87392412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAFD08C1-B0AC-4EB5-BA83-9E879826F869</gtr:id><gtr:title>Improving drug uptake by sonoporation using chirp excitation of polydispersed microbubbles (2013)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd694769dc11e3aa3fd481ae17c645be"><gtr:id>fd694769dc11e3aa3fd481ae17c645be</gtr:id><gtr:otherNames>Stephen Evans (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>m_695117745914073ea6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18534B44-D0B0-44AA-8CB9-9EBA355BA263</gtr:id><gtr:title>Extraction of an overlapped second harmonic chirp component using the fractional fourier transform</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05bd3f2dde73b2c9c539a04beacd7656"><gtr:id>05bd3f2dde73b2c9c539a04beacd7656</gtr:id><gtr:otherNames>Arif M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-1-4577-1253-1</gtr:isbn><gtr:outcomeId>doi_53d0600604fb4b27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBDA2AA3-25F3-4BDE-AB82-FA619AA50C5E</gtr:id><gtr:title>Poly(ethylene glycol) lipid-shelled microbubbles: abundance, stability, and mechanical properties.</gtr:title><gtr:parentPublicationTitle>Langmuir : the ACS journal of surfaces and colloids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19d53cc80b7965e6feb43b726d5851c9"><gtr:id>19d53cc80b7965e6feb43b726d5851c9</gtr:id><gtr:otherNames>Abou-Saleh RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0743-7463</gtr:issn><gtr:outcomeId>56b898b9ebcce2.67170614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAE3D950-F1DD-45B4-B14B-BAD299613A8A</gtr:id><gtr:title>A compact parameterized, real-time interpolating beanformer, benchmarked for parallel beamforming</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14862731c4423a06fdc5f781118dc06e"><gtr:id>14862731c4423a06fdc5f781118dc06e</gtr:id><gtr:otherNames>S Freear (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_40335012541404a6d2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1B030CF-43C5-439C-80C3-BBAC379049DD</gtr:id><gtr:title>Counter flow microbubble channeling using acoustic radiation force funnel</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd80a4ba763938508c97f627b3e6af20"><gtr:id>dd80a4ba763938508c97f627b3e6af20</gtr:id><gtr:otherNames>Raiton B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-1-4577-1253-1</gtr:isbn><gtr:outcomeId>doi_53d06006051b6c51</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>185583B8-73C3-40FF-89C1-843842D4F82B</gtr:id><gtr:title>The effect of liposome loading on the acoustic response of a microbubble population</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd694769dc11e3aa3fd481ae17c645be"><gtr:id>fd694769dc11e3aa3fd481ae17c645be</gtr:id><gtr:otherNames>Stephen Evans (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_714676655514073fc8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0764F0C-5694-457F-946E-39F7BC2B0FF5</gtr:id><gtr:title>Ultrasound array transmitter architecture with high timing resolution using embedded phase-locked loops.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on ultrasonics, ferroelectrics, and frequency control</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/181089f2b06aea2b1287fcf085850c60"><gtr:id>181089f2b06aea2b1287fcf085850c60</gtr:id><gtr:otherNames>Smith PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3010</gtr:issn><gtr:outcomeId>doi_53d05f05fcd7886b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0849DF9F-A879-4B67-9E2E-0C717513EDCD</gtr:id><gtr:title>Seperating the second harmonic response of tissue and microbubbles using bispectral analysis</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b85a0f387e5ab67cc9038114ca25fe3e"><gtr:id>b85a0f387e5ab67cc9038114ca25fe3e</gtr:id><gtr:otherNames>S Harput (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_49014208941404d990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF3FFFFF-E326-4C58-8957-71F54585A7DE</gtr:id><gtr:title>New Treatment for Cancer comes from bursting bubbles (Magazine article)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11d9ec06a3ed3bd1c7f516a675357104"><gtr:id>11d9ec06a3ed3bd1c7f516a675357104</gtr:id><gtr:otherNames>Stephen Evans (Interviewee)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>r_5010834676cac99e30</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D72FEDD-C689-4E2F-BA6B-B2DCF1D5B43E</gtr:id><gtr:title>A three-dimensional viscoelastic finite element model for microbubble non-spherical dynamics near a soft membrane</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e739cee7e01ad6e83ddf2fb5b52c1c8"><gtr:id>9e739cee7e01ad6e83ddf2fb5b52c1c8</gtr:id><gtr:otherNames>G.Y.V Leaute (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_772489257913e088ec</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBC6ECE5-2117-42C7-8735-40304AAEDFDD</gtr:id><gtr:title>Force spectroscopy of streptavidin conjugated lipid coated microbubbles</gtr:title><gtr:parentPublicationTitle>Bubble Science, Engineering &amp; Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff61b808df23c3b9e54421de2a72b21"><gtr:id>9ff61b808df23c3b9e54421de2a72b21</gtr:id><gtr:otherNames>McKendry J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>doi_53d07b07b005c8ed</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>972ACB53-68B3-48FD-83A7-CEB59794F714</gtr:id><gtr:title>Width-modulated square-wave pulses for ultrasound applications.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on ultrasonics, ferroelectrics, and frequency control</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/181089f2b06aea2b1287fcf085850c60"><gtr:id>181089f2b06aea2b1287fcf085850c60</gtr:id><gtr:otherNames>Smith PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3010</gtr:issn><gtr:outcomeId>doi_53d05f05fd330aa9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDBBEED4-C7EE-4E9B-B8D5-F2CEDCB75D0D</gtr:id><gtr:title>Increasing the sonoporation efficiency of targeted polydisperse microbubble populations using chirp excitation.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on ultrasonics, ferroelectrics, and frequency control</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e79a3a86fc1eec9b30094eee6cf6a1"><gtr:id>36e79a3a86fc1eec9b30094eee6cf6a1</gtr:id><gtr:otherNames>McLaughlan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3010</gtr:issn><gtr:outcomeId>doi_53d05f05fd289e5b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4757381D-A916-403C-A0E1-71F237131B8D</gtr:id><gtr:title>Chirp excitation of polydisperse microbubble populations for increasing sonoporation efficiency</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e79a3a86fc1eec9b30094eee6cf6a1"><gtr:id>36e79a3a86fc1eec9b30094eee6cf6a1</gtr:id><gtr:otherNames>McLaughlan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4673-4561-3</gtr:isbn><gtr:outcomeId>doi_53d06006054118c2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD6A0F14-B5FC-4724-B11C-368CF4363B9C</gtr:id><gtr:title>A PLL-based phased array method to minimize phase quantization errors and reduce phasing-lobes</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2476c5e7ee94fae5cfa598d1851e21b"><gtr:id>b2476c5e7ee94fae5cfa598d1851e21b</gtr:id><gtr:otherNames>Smith P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:isbn>978-1-4577-0382-9</gtr:isbn><gtr:outcomeId>doi_53d0600604e06aa7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8495BE46-DF4E-44E9-9425-9802D2D49256</gtr:id><gtr:title>Simple detection of germline microsatellite instability for diagnosis of constitutional mismatch repair cancer syndrome.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ff053ca0ce5d5ebac715757a51b3e6d"><gtr:id>6ff053ca0ce5d5ebac715757a51b3e6d</gtr:id><gtr:otherNames>Ingham D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>doi_53cfc5fc53fe89eb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2778438D-BA57-4C31-A9E5-4036439040F5</gtr:id><gtr:title>Diffusion in low-dimensional lipid membranes.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b19a2bfc0ee277b09c1c580eb06fe73"><gtr:id>2b19a2bfc0ee277b09c1c580eb06fe73</gtr:id><gtr:otherNames>Heath GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn><gtr:outcomeId>doi_55f93d93d8b033c7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E366CC11-CF18-4004-A9A6-22996D20BAF4</gtr:id><gtr:title>Herpesvirus saimiri-mediated delivery of the adenomatous polyposis coli tumour suppressor gene reduces proliferation of colorectal cancer cells.</gtr:title><gtr:parentPublicationTitle>International journal of oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e3df335e482f523c00ec47bc2980fcb"><gtr:id>7e3df335e482f523c00ec47bc2980fcb</gtr:id><gtr:otherNames>Macnab SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1019-6439</gtr:issn><gtr:outcomeId>doi_53d088088626d617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45E96D96-2B32-402E-844D-E8D15BC34544</gtr:id><gtr:title>Exploding gas bubbles could destroy cancer (Newspaper article)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11d9ec06a3ed3bd1c7f516a675357104"><gtr:id>11d9ec06a3ed3bd1c7f516a675357104</gtr:id><gtr:otherNames>Stephen Evans (Interviewee)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>r_4314968844cad3e700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C124DE2-FF33-4011-991F-A2CA7243982E</gtr:id><gtr:title>Non-invasive molecular imaging for preclinical cancer therapeutic development.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ace195de83be263f04433570cd52bf9"><gtr:id>4ace195de83be263f04433570cd52bf9</gtr:id><gtr:otherNames>O'Farrell AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>doi_53d061061204b52a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D842A23-373C-4350-867D-5D32D3081775</gtr:id><gtr:title>On-chip preparation of nanoscale contrast agents towards high-resolution ultrasound imaging.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cfbda786ba46ab2d9fb1bb37c26f09c"><gtr:id>1cfbda786ba46ab2d9fb1bb37c26f09c</gtr:id><gtr:otherNames>Peyman SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn><gtr:outcomeId>56b898b9bce176.38571236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A199FC-B722-4E4B-81F5-055D3E7343E6</gtr:id><gtr:title>Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e9708ab03e5a2ee8ca03108b57b6ec0"><gtr:id>9e9708ab03e5a2ee8ca03108b57b6ec0</gtr:id><gtr:otherNames>Ingram N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>pm_55f93d893d8c081f3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FA099DB-F4C3-4F16-B23A-40F97845602E</gtr:id><gtr:title>Identification of autosomal recessive disease loci using out-bred nuclear families.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e71ddee9bc0132d43e4bad9b9eb4987"><gtr:id>1e71ddee9bc0132d43e4bad9b9eb4987</gtr:id><gtr:otherNames>Carr IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>doi_53cfc5fc53e169c1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE9C2A8E-2192-4701-9151-4B505761A22F</gtr:id><gtr:title>Experimental investigation of chirp coded excitation in ultrasound superharmonic imaging</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cb492fa328916d0f184d6903905f899"><gtr:id>9cb492fa328916d0f184d6903905f899</gtr:id><gtr:otherNames>Muhammad Arif (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>m_196923292713f0fcc2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>778C175B-3810-43F1-A174-78011FC6FC2E</gtr:id><gtr:title>Rapid visualisation of microarray copy number data for the detection of structural variations linked to a disease phenotype.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e71ddee9bc0132d43e4bad9b9eb4987"><gtr:id>1e71ddee9bc0132d43e4bad9b9eb4987</gtr:id><gtr:otherNames>Carr IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_5435b385b38cb174f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA1290E6-C7B3-49A0-91F2-8909454EAEDB</gtr:id><gtr:title>Non-invasive cavitation neuclei trap for histotripsy</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14862731c4423a06fdc5f781118dc06e"><gtr:id>14862731c4423a06fdc5f781118dc06e</gtr:id><gtr:otherNames>S Freear (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_98365156421404a77c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6E2842E-3415-4DBC-A8EB-989AE1C69A29</gtr:id><gtr:title>High-frequency ultrasound for in&amp;nbsp;vivo measurement of colon wall thickness in mice.</gtr:title><gtr:parentPublicationTitle>Ultrasound in medicine &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84148ef69e631100f30458fc40b2023a"><gtr:id>84148ef69e631100f30458fc40b2023a</gtr:id><gtr:otherNames>Abdelrahman MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0301-5629</gtr:issn><gtr:outcomeId>doi_53d00e00ebd4ea7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CC7E49D-BED9-4EF0-9B29-225FF24A5528</gtr:id><gtr:title>Temperature dependent stiffness and visco-elastic behaviour of lipid coated microbubbles using atomic force microscopy</gtr:title><gtr:parentPublicationTitle>Soft Matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d438c3d2685710d922b51b62ae9eee83"><gtr:id>d438c3d2685710d922b51b62ae9eee83</gtr:id><gtr:otherNames>Grant C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53d02e02eb17e99a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C233AA7A-DD96-46C5-9BC9-2822785D6AD8</gtr:id><gtr:title>MethylViewer: computational analysis and editing for bisulfite sequencing and methyltransferase accessibility protocol for individual templates (MAPit) projects</gtr:title><gtr:parentPublicationTitle>Zhonghua hu li za zhi = Chinese journal of nursing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24881ec2f26aa95a76fa1a14a82d13d"><gtr:id>a24881ec2f26aa95a76fa1a14a82d13d</gtr:id><gtr:otherNames>C. E. Pardo (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1986-01-01</gtr:date><gtr:outcomeId>m_330574091313983c36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AAECBAF-057C-4DDA-9B08-0B7C527616D3</gtr:id><gtr:title>Pre-clinical evaluation of VEGFR2 as an imaging biomarker and targeting molecule for therapeutic delivery (2011)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da686138b4c6e2e77f258dbcd9f92457"><gtr:id>da686138b4c6e2e77f258dbcd9f92457</gtr:id><gtr:otherNames>N Ingram (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_433578564513f16a9a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4842BC63-4391-4FD0-AF93-3F224F636323</gtr:id><gtr:title>Bursting bubbles with sound offers new treatments for cancer (Website article)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11d9ec06a3ed3bd1c7f516a675357104"><gtr:id>11d9ec06a3ed3bd1c7f516a675357104</gtr:id><gtr:otherNames>Stephen Evans (Interviewee)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>r_8806139503cad48642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EF71B08-F735-48A6-87BD-18913CF08762</gtr:id><gtr:title>Extraction of spectrally overlapped second harmonic using the fractional fourier transform</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b85a0f387e5ab67cc9038114ca25fe3e"><gtr:id>b85a0f387e5ab67cc9038114ca25fe3e</gtr:id><gtr:otherNames>S Harput (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_30327878761404d742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA0E5FD4-C7FE-4BDA-925C-FC15DA93F103</gtr:id><gtr:title>Autozygosity mapping with exome sequence data.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e71ddee9bc0132d43e4bad9b9eb4987"><gtr:id>1e71ddee9bc0132d43e4bad9b9eb4987</gtr:id><gtr:otherNames>Carr IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>doi_53cfc5fc53f5e75d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>307C5DDE-4DE9-49AB-A050-617C4887CDFC</gtr:id><gtr:title>Phase-inversion-based selective harmonic elimination (PI-SHE) in multi-level switched-mode tone- and frequency-modulated excitation.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on ultrasonics, ferroelectrics, and frequency control</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ae5dafef359b1ce48b9cc617060f66d"><gtr:id>5ae5dafef359b1ce48b9cc617060f66d</gtr:id><gtr:otherNames>Cowell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3010</gtr:issn><gtr:outcomeId>doi_53d05f05fcf4e317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36C616E0-583C-451C-98C0-651838544125</gtr:id><gtr:title>A fractional harmonic excitation (FHE) method for high frequency array imaging</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2476c5e7ee94fae5cfa598d1851e21b"><gtr:id>b2476c5e7ee94fae5cfa598d1851e21b</gtr:id><gtr:otherNames>Smith P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4673-4561-3</gtr:isbn><gtr:outcomeId>doi_53d06006055068ac</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A66B43C3-F8AF-4123-9BA5-C5573B994248</gtr:id><gtr:title>Fabrication of lipid tubules with embedded quantum dots by membrane tubulation protein.</gtr:title><gtr:parentPublicationTitle>Small (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b53dddc4810d58a033a44ad9fc273d40"><gtr:id>b53dddc4810d58a033a44ad9fc273d40</gtr:id><gtr:otherNames>Tanaka M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1613-6810</gtr:issn><gtr:outcomeId>doi_53cfcafca76c3c13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB24C8C2-BDE9-458D-8850-54FB1BC17448</gtr:id><gtr:title>Nanomechanics of lipid encapsulated microbubbles with functional coatings.</gtr:title><gtr:parentPublicationTitle>Langmuir : the ACS journal of surfaces and colloids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19d53cc80b7965e6feb43b726d5851c9"><gtr:id>19d53cc80b7965e6feb43b726d5851c9</gtr:id><gtr:otherNames>Abou-Saleh RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0743-7463</gtr:issn><gtr:outcomeId>doi_53d01a01a959abff</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>998FDC53-51D1-4310-9732-52FEF55EA378</gtr:id><gtr:title>The use of high-frequency ultrasound imaging and biofluorescence for in vivo evaluation of gene therapy vectors.</gtr:title><gtr:parentPublicationTitle>BMC medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e9708ab03e5a2ee8ca03108b57b6ec0"><gtr:id>9e9708ab03e5a2ee8ca03108b57b6ec0</gtr:id><gtr:otherNames>Ingram N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2342</gtr:issn><gtr:outcomeId>doi_55f93d93d8c939fe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17C45102-DD77-4831-ACD4-38D2D31B86F8</gtr:id><gtr:title>Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c59835b27395f668dc48a4dd07b201e"><gtr:id>7c59835b27395f668dc48a4dd07b201e</gtr:id><gtr:otherNames>Kant P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>doi_53d071071c5f31d5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2951938-D071-4B9A-9985-20A10F77C244</gtr:id><gtr:title>The use of optically activated nanoparticles to enhance controlled lesion formation from high intensity focused ultrasound exposures</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e79a3a86fc1eec9b30094eee6cf6a1"><gtr:id>36e79a3a86fc1eec9b30094eee6cf6a1</gtr:id><gtr:otherNames>McLaughlan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-1-4577-1253-1</gtr:isbn><gtr:outcomeId>doi_53d060060511f144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F9FB10D-7E15-468D-8DC8-0EC88E0769DC</gtr:id><gtr:title>Determining the Concentration of CuInS
 
 Quantum Dots from the Size-Dependent Molar Extinction Coefficient</gtr:title><gtr:parentPublicationTitle>Chemistry of Materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebccfe7208e85c1c483f80303f097a8d"><gtr:id>ebccfe7208e85c1c483f80303f097a8d</gtr:id><gtr:otherNames>Booth M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53d014014f12adf0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/I000623/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>B30DC286-3309-48E2-A15D-BDF547057A33</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Drug Formulation &amp; Delivery</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>16595C3C-600D-4AD2-B394-16E06F96495F</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Med.Instrument.Device&amp; Equip.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>